BridgeBio Pharma Inc. (BBIO) Tops Q1 EPS by 3c

BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q1 EPS of ($0.88), $0.03 better than the analyst estimate of ($0.91). Revenue for the quarter came in at $116.63 million versus the consensus estimate of $54.46 million.

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.

You May Also Be Interested In

• BridgeBio Pharma (BBIO) PT Raised to $115 at Piper Sandler as 'Attruby Outperforms'
• Kepler Cheuvreux Downgrades Merlin Properties SA (MRL:SM) (MRPRF) to Hold
• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02